• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌生物学与遗传学

Pancreatic cancer biology and genetics.

作者信息

Bardeesy Nabeel, DePinho Ronald A

机构信息

Department of Adult Oncology, Dana-Farber Cancer Institute and Departments of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Nat Rev Cancer. 2002 Dec;2(12):897-909. doi: 10.1038/nrc949.

DOI:10.1038/nrc949
PMID:12459728
Abstract

Pancreatic ductal adenocarcinoma is an aggressive and devastating disease, which is characterized by invasiveness, rapid progression and profound resistance to treatment. Advances in pathological classification and cancer genetics have improved our descriptive understanding of this disease; however, important aspects of pancreatic cancer biology remain poorly understood. What is the pathogenic role of specific gene mutations? What is the cell of origin? And how does the stroma contribute to tumorigenesis? A better understanding of pancreatic cancer biology should lead the way to more effective treatments.

摘要

胰腺导管腺癌是一种侵袭性强且极具破坏性的疾病,其特征为具有侵袭性、进展迅速且对治疗具有高度抗性。病理分类和癌症遗传学的进展增进了我们对这种疾病的描述性认识;然而,胰腺癌生物学的重要方面仍了解甚少。特定基因突变的致病作用是什么?起源细胞是什么?以及基质如何促进肿瘤发生?对胰腺癌生物学的更好理解应能引领出更有效的治疗方法。

相似文献

1
Pancreatic cancer biology and genetics.胰腺癌生物学与遗传学
Nat Rev Cancer. 2002 Dec;2(12):897-909. doi: 10.1038/nrc949.
2
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.胰腺腺癌的遗传学:小鼠模型路线图
Semin Cancer Biol. 2001 Jun;11(3):201-18. doi: 10.1006/scbi.2000.0371.
3
The role of the tumor microenvironment in the progression of pancreatic cancer.肿瘤微环境在胰腺癌进展中的作用。
J Surg Res. 2008 Oct;149(2):319-28. doi: 10.1016/j.jss.2007.12.757. Epub 2008 Jan 10.
4
Molecular aspects of carcinogenesis in pancreatic cancer.胰腺癌发生的分子机制
Hepatobiliary Pancreat Dis Int. 2008 Aug;7(4):345-56.
5
Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.胰腺导管肿瘤:疾病分类学、临床病理学及生物学方面
Semin Radiat Oncol. 2005 Oct;15(4):254-64. doi: 10.1016/j.semradonc.2005.04.001.
6
[Precursors to pancreatic cancer].[胰腺癌的前驱病变]
Tidsskr Nor Laegeforen. 2006 Mar 23;126(7):905-8.
7
RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.RNA干扰抑制MUC1可降低人胰腺癌细胞的生长速率和转移表型。
Clin Cancer Res. 2006 May 15;12(10):2976-87. doi: 10.1158/1078-0432.CCR-05-1197.
8
BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.骨钙素在胰腺癌细胞中表达,并增加其生长和侵袭能力。
Mol Cancer. 2007 Dec 28;6:83. doi: 10.1186/1476-4598-6-83.
9
Core signaling pathways and new therapeutic targets in pancreatic cancer.胰腺癌的核心信号通路和新的治疗靶点。
Chin Med J (Engl). 2010 May 5;123(9):1210-5.
10
Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.大鼠胰腺中人类Ha-ras癌基因条件性激活诱导的胰腺腺癌的导管起源
Carcinogenesis. 2006 Dec;27(12):2497-510. doi: 10.1093/carcin/bgl090. Epub 2006 Jun 13.

引用本文的文献

1
Immune checkpoint inhibitors in pancreatic adenocarcinoma: a systematic review and meta analysis of clinical outcomes.胰腺腺癌中的免疫检查点抑制剂:临床结局的系统评价和荟萃分析
Front Oncol. 2025 Aug 8;15:1569884. doi: 10.3389/fonc.2025.1569884. eCollection 2025.
2
Emerging Multifunctional Carbon-Nanomaterial-Based Biosensors for Cancer Diagnosis.用于癌症诊断的新型多功能碳纳米材料基生物传感器
Small Sci. 2024 Jan 22;4(3):2300221. doi: 10.1002/smsc.202300221. eCollection 2024 Mar.
3
Contrast-enhanced MRI-based intratumoral heterogeneity assessment for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma.
基于对比增强磁共振成像的瘤内异质性评估对可切除胰腺导管腺癌淋巴结转移的预测作用
Insights Imaging. 2025 Mar 30;16(1):76. doi: 10.1186/s13244-025-01956-0.
4
Fast-Relaxing Hydrogels Promote Pancreatic Adenocarcinoma Cell Aggressiveness through Integrin β1 Signaling.快速松弛水凝胶通过整合素β1信号通路促进胰腺腺癌细胞的侵袭性。
Biomacromolecules. 2025 Feb 10;26(2):1098-1110. doi: 10.1021/acs.biomac.4c01441. Epub 2025 Jan 22.
5
Exosomes as promising frontier approaches in future cancer therapy.外泌体作为未来癌症治疗中颇具前景的前沿方法。
World J Gastrointest Oncol. 2025 Jan 15;17(1):100713. doi: 10.4251/wjgo.v17.i1.100713.
6
A mathematical model for pancreatic cancer during intraepithelial neoplasia.上皮内瘤变期间胰腺癌的数学模型。
R Soc Open Sci. 2024 Oct 30;11(10):240702. doi: 10.1098/rsos.240702. eCollection 2024 Oct.
7
Metachromin C, a marine-derived natural compound, shows potential in antitumor activity.色氨酰 C,一种海洋来源的天然化合物,具有抗肿瘤活性的潜力。
Int J Med Sci. 2024 Oct 7;21(13):2578-2594. doi: 10.7150/ijms.101037. eCollection 2024.
8
Unraveling the interplay: exploring signaling pathways in pancreatic cancer in the context of pancreatic embryogenesis.揭示相互作用:在胰腺胚胎发生背景下探索胰腺癌中的信号通路。
Front Cell Dev Biol. 2024 Aug 22;12:1461278. doi: 10.3389/fcell.2024.1461278. eCollection 2024.
9
Exploring the molecular mechanisms and therapeutic potential of SMAD4 in colorectal cancer.探讨 SMAD4 在结直肠癌中的分子机制和治疗潜力。
Cancer Biol Ther. 2024 Dec 31;25(1):2392341. doi: 10.1080/15384047.2024.2392341. Epub 2024 Aug 20.
10
Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer.维奈克拉靶向 BCL2 增强 KRASG12D 抑制剂 MRTX1133 在胰腺癌中的疗效。
Cancer Res. 2024 Nov 4;84(21):3629-3639. doi: 10.1158/0008-5472.CAN-23-3574.